Noticias de ACAD_US
Noticias del mercado
Últimas noticias sobre ACAD_US — 136 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.
Acadia Pharmaceuticals announces retirement of R&D head, names interim consultant
Form 8K ACADIA Pharmaceuticals Inc For: 23 October By Investing.com
Find the latest Acadia Pharmaceuticals Inc. (ACAD) stock quote, history, news and other vital information to help you with your stock trading and investing.
ACADIA Pharmaceuticals Inc. (ACAD) Stock Forecasts
En Yahoo Finance, obtienes cotizaciones de acciones gratuitas, noticias actualizadas, recursos de gestión de carteras, datos de mercados internacionales, interacción social y tasas hipotecarias que te ayudarán a gestionar tu vida financiera.
En Yahoo Finance, obtienes cotizaciones de acciones gratuitas, noticias actualizadas, recursos de gestión de carteras, datos de mercados internacionales, interacción social y tasas hipotecarias que te ayudarán a gestionar tu vida financiera.
At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.
Acadia Pharmaceuticals Inc. (ACAD) stock price, news, quote and history
SAN DIEGO, October 21, 2026--Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that it will report third quarter 2026 financial results on Wednesday, November 4, 2026, after the close of the U.S. financial markets. Acadia’s management team will also host a conference call and webcast on November 4, 2026, at 4:30 p.m. Eastern Time.
Acadia Pharmaceuticals to Announce Third Quarter 2026 Financial Results on November 4, 2026
NEW YORK, Oct. 20, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of ACADIA Pharmaceuticals Inc. (“Acadia” or the “Company”) (NASDAQ: ACAD). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
ACADIA reported Q2 revenue of USD 308.00 million, up 16.40 percent year over year. ACADIA Pharmaceut
Los ingresos alcanzaron los 308,00 millones de dólares, un aumento interanual del 16,40 por ciento. Acciones de ACADIA Pharmaceuticals cerradas
Revenue hit USD 308.00 million, up 16.40 percent year over year. ACADIA Pharmaceuticals stock closed
At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.
Página 1 de 7